Blocking Src-PSD-95 interaction rescues glutamatergic signaling dysregulation in schizophrenia.
Robert E. Featherstone, Hongbin Li, Ameet S. Sengar, Karin E. Borgmann‐Winter, Olya Melnychenko, Lindsey M. Crown, Raymond L. Gifford, Felix Amirfathi, Anamika Banerjee, Krishna Parekh, Margaret Heller, Wenyu Zhang, Adam D. Marc, Michael W. Salter, Steven J. Siegel, Chang-Gyu Hahn
This study shows that blocking the Src-PSD-95 interaction with a peptide rescues NMDAR hypofunction and improves behavioral deficits in schizophrenia models.
bioRxiv · Mar 8, 2024 · PreprintNeuroscience